Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
      Google Scholar   
Citation:
J Clin Oncol vol 25 (24) 3699-704
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Comprehensive
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
CA32291, CA33601, CA35279, CA60138, CA77406, CA77651, CAII028  
Corr. Author:
 
Authors:
                   
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8541, CALGB-9741
Phases:
3
Keywords:
Age Factors, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Chemotherapy, Adjuvant, Cyclophosphamide, Doxorubicin, Female, Humans, Leukemia, Myeloid, Acute, Lymphatic Metastasis, Middle Aged, Myelodysplastic Syndromes, Neoplasms, Second Primary, Paclitaxel